Stryker (NYSE:SYK) won a round in its lawsuit against upstart rival Blue Belt Technologies and its new hire, a former Stryker marketing director, after a federal judge barred the ex-employee from attending this week’s annual conference of the American Academy of Orthopedic Surgeons.
Stryker
FDA blames poor training for new deaths, injuries tied to Stryker’s recalled Neptune systems
MassDevice.com +7 | The top 7 med-tech stories for the week of March 11, 2013
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Stryker buys VertiFlex spinal implant assets
Stryker‘s (NYSE:SYK) spine division acquired some non-core assets from medical device company VertiFlex for an undisclosed amount.
San Clemente, Calif.-based VertiFlex said the technology is "not core to the ongoing strategic operations of the company" and that it plans to us the cash for its line of lumbar spinal stenosis products.
FDA warns Stryker on quality systems, recalls, Neptune marketing
Stryker (NYSE:SYK) said today that the FDA sent it a warning letter stemming from an November 2012 inspection of a plant in Portage, Mich.
The Kalamazoo, Mich.-based medical device company said the letter, based on "quality system observations," flagged it for failing to tell the federal watchdog agency of a product recall and for marketing devices including its Neptune waste management system without 510(k) clearance from the FDA.
The Chinese medical device market: Driven by both growth and value
by Stephen D. Simpson, CFA
Venezuelan currency shift lowers Johnson & Johnson’s Q1 outlook | Wall Street Beat
Healthcare giant Johnson & Johnson (NYSE:JNJ) expects to incur a charge of about $100 million in its 1st quarter of 2013 due to the negative impact of the Venezuelan government’s decision to devalue its currency, the company reported in a regulatory filing.
When it comes to robots, opinions run hot
Stryker recommends more vigilant monitoring of patients with recalled hip implants
Stryker hits a 52-week high | Wall Street Beat
Shares of Stryker (NYSE:SYK) hit a 52-week high yesterday, peaking at $64.46 apeice before closing at $63.88, down 0.2% on the day.
STK shares are up about 3% since the medical device company reported 4th-quarter and 2012 results Jan. 24. Stryker said yesteday that it plans to issue a 26.5¢ dividend to shareholders.